The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Health Service Policy
A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.
A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England.
Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there's huge variation between referrals.
NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.
Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.
One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.
A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.
Linking cancer drug prices to treatment success could speed up approvals. But what do patients consider success?
With NHS budgets stretched, it’s critical that cancer drugs offer value for money. We’ve teamed up with the Greater Manchester Health and Social Care Partnership to...